Skip to main content
OpenTrials

Clinical trial condition

Trophoblastic Neoplasms

Explore clinical trials studying Trophoblastic Neoplasms. Study availability and eligibility vary by location and protocol.

50 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Trophoblastic Neoplasms trial results

Completed

Campath-1H + FK506 and Methylprednisolone for GVHD

NCT00109993

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +109 more
Locations
  • Mt. Sinai Medical Center New York, United States
  • Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Oregon Health Sciences University Portland, Oregon, United States
View Trial Details
Active, Not Recruiting

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

NCT06790706

Conditions
Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
Locations
  • Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
  • Institut Bergonié, medical oncology department Bordeaux, France
  • Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
  • Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
View all 15 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors

NCT02375204

Conditions
Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 125 locations
View Trial Details

Related conditions